The pathophysiology of anxiety disorders has come to the forefront of scientific research in recent years. This has allowed for the development of several pharmaceuticals used in anxiety treatment. Specific anxiety disorders discussed are panic disorder (PD), generalized anxiety disorder (GAD), and social anxiety disorder (SAD). These new medications have led to improved outcomes for patients with anxiety.
Research into the pathophysiology of anxiety disorders found that overactivity occurs in the limbic regions of the brain, including the amygdala and insula, while processing emotional stimuli. It is suggested that neurotransmitters that mediate these networks can be targets for pharmacological treatment.
Several interventions in the treatment of anxiety and panic disorders are discussed, as well as treatment plan management suggestions.
Citation:
Wilson, A. J., & Stein, D. J. (2019). Pharmacological treatment of anxiety disorders. In S. M. Evans & K. M. Carpenter (Eds.), APA handbook of psychopharmacology. (pp. 195–215). American Psychological Association. https://doi-org.ezproxy.library.uvic.ca/10.1037/0000133-009
Closed Access
